MY CARE PLUS
Introducing a New Convenient Way to Connect: Online! The Message Center is a new feature that allows you to securely communicate with your care team through the online portal, My Care Plus . SM
You may use the Message Center for non-urgent* topics like: • • • •
Scheduling appointments and cancellations Diagnostics preparation Questions about lab results Non-urgent medication questions
To use the Message Center, enroll in My Care Plus by completing and submitting the consent form at the front desk. * For urgent matters, contact our office or call 911.
www.MyCarePlusOnline.com
My Care Plus Instructions To send and receive messages through the Message Center: 1. Log in to My Care Plus www.MyCarePlusOnline.com
1
2
2. Click the Message Center link
To send a message: 3. Click Compose Message from the menu 4. Select your doctor, enter your subject and message, and click Send
To view and reply to your received messages: • Click the Inbox link • Click anywhere on the message to open and read
3
• U se the Reply Message box at the bottom to enter your message, and click Reply
If you have questions regarding enrollment in My Care Plus, please contact our office. If you need assistance with the Message Center, please contact My Care Plus Support by email at Support@MyCarePlusOnline.com or call 855.887.6788. www.MyCarePlusOnline.com
• Your care team will make every attempt to respond to your messages quickly, but some responses may take up to 48 hours.
• A staff member, such as a nurse or administrative staff, may respond to your message on behalf of your doctor.
• Do not use the Message Center for emergencies.
www.MyCarePlusOnline.com The US Oncology Network is supported by McKesson Specialty Health. © 2014 McKesson Specialty Health. All rights reserved.
4
HAVE A QUESTION FOR US? Use the Message Center to connect with us today! For urgent matters, contact our office or call 911.
www.MyCarePlusOnline.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2014 McKesson Specialty Health. All rights reserved.
MY CARE PLUS: MESSAGE CENTER
A NEW WAY TO CONNECT
Introducing the My Care Plus Message Center A secure way to send us non-urgent* messages at your convenience. Ask for details to get started, and we’ll be happy to help. * Do not use the Message Center for emergencies.
www.MyCarePlusOnline.com
The US Oncology Network is supported by McKesson Specialty Health. © 2014 McKesson Specialty Health. All rights reserved.
Cloverly 200
Aspen Hill
Burtonsville
95
7350 VAN DUSEN ROAD, STE. 370 LAUREL, MD 20707
Colesville 1 95
12210 PLUM ORCHARD DR, STE. 211 SILVER SPRING, MD 20904
Wheaton Glenmont
2730 UNIVERSITY W BLVD, STE. 400 SILVER SPRING, MD 20902
White Oak
Beltsville
193
Adelphi
495 29
7525 GREENWAY CENTER DRIVE, STE 205 GREENBELT, MD 20770 1
Silver Spring
College Park
MyCarePlusOnline.com
My Care Plus:
Get secure, convenient access to information about your diagnosis, lab results, medications and more.
Enroll Today! We are pleased to offer you this valuable service providing you online access to your Personal Health Record. Simply tell our staff you’re interested, and we’ll help you get started.
G enetic C ounseling -R eferral C riteria APPROXIMATELY 10% OF ALL CANCERS ARE HEREDITARY
H ereditary B reast
and
O varian C ancer
REFER PATIENTS THAT MEET ANY OF THE FOLLOWING CRITERIA:
❑ ❑ ❑ ❑ ❑ ❑ ❑
Breast Cancer under age 50 Bilateral Breast Cancer Ovarian Cancer at any age Male breast cancer in patient or family member Ashkenazi Jewish Ancestry with Personal or Family History of Breast/Ovarian Cancer > 2 Close Blood Relatives with Breast Cancer and/or Ovarian Cancer Triple Negative (ER-, PR-, HER2-) Breast Cancer < 60 Breast Cancer includes DCIS and Invasive Cancers.
O ther C riteria ❑ Bilateral or multiple primary cancers ❑ Rare tumors such as medullary thyroid carcinoma, paragangliomas or pheochromocytomas ❑ Known gene mutation in family
H ereditary C olon C ancer REFER PATIENTS THAT MEET ANY OF THE FOLLOWING CRITERIA:
❑ Colorectal (CRC) Cancer < 50 years ❑ Colon Cancer < 60 years with MSI-H histology (tumor infiltrating lymphocytes, Crohn’s like lymphocytic reaction, mucinous/signet-ring differentiation, or medullary growth pattern) ❑ Two or more primary CRC’s or Lynch related tumors* ❑ > 3 Family members, same side of the family, with CRC, Uterine, Ovarian or other Lynch related tumors ❑ > 10 GI Adenomas (pre-cancerous polyps) ❑ Multiple Hamartomatous (Juvenile) GI Polyps *Uterine, Ovarian, Gastric, Pancreatic, Urinary Tract, Sebaceous Tumor, and Brain Tumors
The initial appointment at MOH involves a consult with a medical oncologist Columbia • Silver Spring • Greenbelt • Laurel • Owings Mills • Gettysburg, PA www.MDOnc.com
Maryland_Cancer101_Press_2712.pdf 1 2/7/2012 12:30:58 PM
PATIENT PLANNER B A S I C S F O R T H E N E WLY DIAGN OSE D
A P L AN N E R F OR P E OP L E WI T H CANCE R AND THE I R CAR E G I V E R S
www.M D ONC.c om
Maryland_Cancer101_Press_2712.pdf 2 2/7/2012 12:30:59 PM
Columbia Silver Spring Greenbelt
Our mission is to deliver on the promise of providing the best patient care possible in a caring and supportive environment; with
Laurel
seamless access to the latest in technology
Owings Mills
and research available to help every patient
Gettysburg, PA
live their highest quality of life.
MARCH IS COLORECTAL CANCER AWARENESS MONTH
Don’t be Chicken
Get Screened Today. Diets high in red or processed meat can increase the risk of developing colorectal cancer. Screening for colorectal cancer can find polyps early, before they turn into cancer. Screening tests available include a colonoscopy, imaging scans and blood tests. While most people should begin screening at age 50, if you are at increased risk of developing colorectal cancer, speak with your doctor about the benefits of screening earlier, having additional tests or having more frequent exams. Also, report to your doctor any change in your bowel habits, such as diarrhea, constipation, narrower than-usual stool, blood in your stool, or frequent gas or cramps. Risk Factors for Colorectal Cancer: • Age over 50 • History of colorectal polyps or colorectal cancer • History of inflammatory bowel disease • Family history of colorectal cancer • Obesity
• • • • •
African American or Jewish of Eastern European decent A diet that is high in red and/or processed meats Physical inactivity Smoking Type 2 Diabetes
Kashif Ali, MD • Thomas A. Bensinger, MD, FACP • Alida Espinoza, MD Kashif Firozvi, MD • Frederick Min, MD • Martin D. Weltz, DO, FACP, MBA, MPH Greenbelt 7525 Greenway Center Drive Suite 205 Greenbelt, MD 20770 (301) 982-9800 www.MDOnc.com
Laurel 7350 Van Dusen Road Suite 370 Laurel, MD 20707 (301) 982-9800
Silver Spring 2101 Medical Park Drive Suite 200 Silver Spring, MD 20902 (301) 933-3216
MOH_Pikesville_Growth_OpenHouseFlyer_outlines.indd 1
4/20/2012 5:06:59 PM
MOH_Pikesville_Growth_OpenHouseFlyer_outlines.indd 2
4/20/2012 5:07:02 PM
We are Proud to Announce our new
LOCATION
Westminster
MOH_Westminster_Growth_Flyer.indd 1
5/21/2012 5:08:36 PM
w e hav e a ne w
westminster address
Maryland Oncology Hematology is pleased to announce we have opened a new office in Westminster. We remain committed to providing the best oncology and hematology services in a community setting close to home. In our new state of the art infusion center, we offer todayâ&#x20AC;&#x2122;s most effective therapies, expertly and compassionately delivered.
our new address 680 Poole Road Westminster, MD 21157 To refer a patient, please call (410) 581-2100
Mohit Narang, MD
MOH_Westminster_Growth_Flyer.indd 2
MDONC.COM
Robert RICE, MD, PhD
5/21/2012 5:08:46 PM
Providing comprehensive, compassionate care.
Our dedicated physicians, nurses and staff provide a full range of cancer care services including chemotherapy, laboratory testing, clinical trials and support services. We are united in healing with The US Oncology Network, one of the nation’s largest communitybased cancer treatment and research networks dedicated to expanding patient access to high-quality care.
Mohit Narang, MD
Robert Rice, MD, PhD
Manoj Agarwal, MD, MBA
Medical Oncology & Hematology
Medical Oncology & Hematology
Medical Oncology & Hematology
Pikesville • 1838 Greene Tree Rd., Suite 260 • Pikesville, MD 21208 • (410) 581-2100 Westminster • 680 Poole Rd., Suites A & B • Westminster, MD 21157 • (410) 581-2100 Gettysburg • 40 V Twin Dr., Suite 104 • Gettysburg, PA 17325 • (717) 338-9009
www.mdonc.com
12071902.indd 1
7/24/12 1:41 PM
Celebration of Life Gathering Please join us in celebrating the life and times of
Clement B. Knight, M.D. Friends, colleagues, and patients are invited to celebrate the memories of a life well-lived. August 30, 2012 4-7 pm Maryland Oncology Hematology 10710 Charter Dr G020 Columbia, Maryland 21044 Donations can be made in honor of Clement B. Knight, M.D to the Clement B. Knight, M.D. Patient Assistance Fund C/o Maryland Oncology Hematology, P.A.
2730 University W Blvd. Suite 400 Wheaton, MD 20902
Cheryl A. Aylesworth, M.D. Linda M. Burrell, M.D.
Maryland Oncology Hematology, P.A. 2730 University W Blvd., Suite 400 Wheaton, MD 20902 phone (301) 942-9220 fax (301) 942-9223 www.mdonc.com
October 2012
Dear Colleague, We are pleased to inform you that we have joined the talented physician team of Maryland Oncology Hematology, P.A. By joining Maryland Oncology Hematology, we are able to provide our patients with expanded access to the latest treatment therapies and increased opportunities to participate in ground-breaking clinical trials while continuing to provide the same exceptional care our patients have come to expect. Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest networks of community-based oncology physicians dedicated to advancing cancer care in America. As an affiliate of The US Oncology Network, we are able to collaborate with the 13 other physicians of Maryland Oncology Hematology, as well as approximately 1,000 physicians nationwide. We will continue to see patients at our Wheaton location: 2730 University W Blvd., Suite 400 Wheaton, MD 20902 Phone: (301) 942-9220 In early 2013, we will be relocating from our Wheaton office listed above to 2101 Medical Park Drive, Suite 200, Silver Spring, MD 20902. At our Silver Spring location, we will be able to provide a comprehensive cancer care experience to our patients coupled with consolidated radiation and imaging services. We will also be exploring opportunities for clinic hours in Greenbelt and Laurel. Please feel free to let the front desk staff know if this is of interest to you. Our privileges include hematology and oncology at Holy Cross, MGH and Suburban hospitals. Privileges are pending at WAH. Most insurance plans are accepted. We are excited to continue to bring expert cancer care to our patients and their families. Our first priority is, and will always be, our patients. We appreciate your trust and confidence and look forward to our continued relationship. Sincerely,
Cheryl A. Aylesworth, M.D.
Linda M. Burrell, M.D.
JOINING FORCES IN THE FIGHT.
Maryland Oncology Hematology is pleased to announce the addition of Cheryl A. Aylesworth, M.D. and Linda M. Burrell, M.D. to our physician staff. 12091804.indd 1
11/1/12 10:52 AM
E X P E RT P H Y S I C I A N S . EXCEPTIONAL CARE.
2730 University W Blvd. Suite 400 Wheaton, MD 20902
At Maryland Oncology Hematology, we believe the best care is both advanced and compassionate. Our philosophy is to care for the whole person, not just fight the disease. We are proud to welcome Dr. Cheryl A. Aylesworth and Dr. Linda M. Burrell to our team of board certified physicians. Together, we will continue to provide patients with the latest cutting-edge treatments and options in their fight against cancer. Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest community-based cancer treatment and research networks dedicated to expanding patient access to high-quality care. Dr. Aylesworth and Dr. Burrell will continue to see patients at their Wheaton Location: 2730 University W Blvd. Suite 400 Wheaton, MD 20902 Phone: (301) 942-9220 Fax: (301) 942-9223
Cheryl A. Aylesworth, M.D.
Linda M. Burrell, M.D.
www.MDOnc.com
12091804.indd 2
11/1/12 10:52 AM
It is with profound sadness and heavy hearts, we remember our dear friend and colleague, Clement B. Knight, M.D., who passed on August 9, 2012. Those of us who were fortunate to know Clement have lost a dear friend, colleague and an outstanding physician. No words can adequately express our sadness at his passing or our gratitude for the opportunity to have worked with him.
Clement B. Knight, M.D.
www.mdonc.com
The Physicians and Staff of Maryland Oncology Hematology, P.A.
Providing comprehensive, compassionate care. Our dedicated physicians, nurses and staff provide individualized wellness plans for patients with access to a full range of cancer care services including chemotherapy, laboratory testing, clinical trials and support services. We are united in healing with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest community-based cancer treatment and research networks dedicated to expanding patient access to high-quality care.
Silver Spring 301-933-3216
Greenbelt/Laurel 301-982-9800
Wheaton 301-942-9220
Kashif Ali, M.D. Roopa De Chowdhury, M.D. Alida Espinoza, M.D. Kashif Firozvi, M.D. Frederick Min, M.D. Kristin Sorenson, NP-C, MS, RN
Kashif Ali, M.D. Thomas A. Bensinger, M.D., F.A.C.P. Roopa De Chowdhury, M.D. Alida Espinoza, M.D. Ayana M. Elliott, D.N.P., C.R.N.P.
Cheryl Aylesworth, M.D. Linda Burrell, M.D.
www.mdonc.com
Physician Contact Card Medical Oncology and Hematology
Thomas A. Bensinger, MD, FACP 301-717-5758
Kashif Firozvi, MD 202-210-8633
Frederick Min, MD 202-744-7921
Alida Espinoza, MD 443-629-8499
Thomas.Bensinger@usoncology.com Greenbelt
Kashif.Firozvi@usoncology.com Silver Spring
David.Min@usoncology.com Silver Spring
Alida.Espinoza@usoncology.com Silver Spring & Greenbelt
Kashif Ali, MD 410-404-2500
Roopa DeChowdhury, MD 202-550-9222
Cheryl A. Aylesworth, MD 301-802-0231
Linda M. Burrell, MD 301-801-5951
Kashif.Ali@usoncology.com Silver Spring, Greenbelt & Laurel
Roopa.DeChowdhury@usoncology.com Silver Spring, Greenbelt & Laurel
Cheryl.Aylesworth@usoncology.com Wheaton
Linda.Burrell@usoncology.com Wheaton
Services
We See Patients At:
• Physician evaluation and treatment planning
• Holy Cross Hospital
for blood disorders and cancer care
• Washington Adventist Hospital
• Second opinion services
• Suburban Hospital
• Chemotherapy and infusion therapy
• Laurel Regional Hospital
• Therapeutic phlebotomies
• Doctors Community Hospital
• Maintenance of IV devices • Laboratory services by a state accredited lab • Bone marrow biopsies • Administration of injections for the treatment of cancer and hematological disorders • Access to complementary and alternative medicine
Greenbelt
Silver Spring
Wheaton
Laurel
7525 Greenway Center Drive Suite 205 Greenbelt, MD 20770 301-982-9800
2101 Medical Park Drive Suite 200 Silver Spring, MD 20902 301-933-3216
2730 University W Blvd. Suite 400 Silver Spring, MD 20902 301-942-9220
7350 Van Dusen Road Suite 370 Laurel, MD 20707 301-982-9800
www.MDONC.com
What is Patient Assistance Support? • Patient Assistance Support (PAS) consists of a team of specialists that work in collaboration with our financial counselors to explore and provide access to the best funding options available for your diagnosis and treatment. • PAS is offered to you free of charge to connect you to a range of support, tailored to your situation:
The cost of cancer care can be overwhelming…
a
Contact Us Today PAS Representative: 866.744.8766
✓✓ Do you have insurance with a co-pay for medications? ✓✓ Do you use Medicare? ✓✓ Do you have limited coverage or no health insurance at all? ✓✓ Do you seek support even though you may think you are “over income”? We estimate income guidelines for you.
Seeking financial assistance doesn’t have to be.
…PAS can help! Patient Assistance Support is offered to our patients in collaboration with The US Oncology Network and McKesson Specialty Health – providing the advanced care you’d expect from one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America.
© 2013 McKesson Specialty Health. All rights reserved.
PATIENT ASSISTANCE SUPPORT
You’re not alone in your search for financial assistance.
Tips for getting started.
1
SCHEDULE A PERSONAL CONSULTATION WITH OUR FINANCIAL COUNSELOR
• Simply call our office to set up a free consultation with a financial counselor/patient benefit representative. He/she can help you determine the type of budgeting support or financial assistance you may need based on the extent of your health insurance coverage and the length and type of your prescribed cancer treatment plan.
Battling cancer can be daunting enough without having to worry about the affordability of care. We work with manufacturers and community organizations to help qualified patients obtain financial assistance to enable them to get the care they need. You may have questions about the cost of your treatment and how much your insurance will cover. We understand how quickly out-of-pocket expenses can add up, which is why we are pleased to extend Patient Assistance Support (PAS) at no charge to you. PAS can help you to navigate the financial aspects of your care plan and evaluate assistance options that may help with your cancer care costs.
• The counselor/ patient benefit representative will collaborate with your physician to suggest ways to reduce medical and associated costs and assign you a PAS specialist with knowledge of the support services that may be available to address your situation. • To make the most of your cost-of-care consultation and uncover all options, please come prepared with the following:
✓✓ A list of your concerns and questions regarding your insurance benefits or your ability to cover your costs ✓✓ The most recent benefits statement from your insurer ✓✓ All insurance cards, including insurance or discount cards for hospital and prescription costs ✓✓ A friend or family member to support you
2
LET PAS ASSIST YOU WITH THE FINANCIAL APPLICATION PROCESS
Once you have completed your financial consultation and it is determined that seeking financial support is a good option for you, a PAS specialist can guide you through the process of applying for assistance through non-profit organizations or manufacturer assistance programs. PAS will recommend a variety of resources available that are applicable to you. If you would like PAS to assist you with processing applications, you will simply need to: 1. Sign a form provided by your financial counselor authorizing PAS to complete applications on your behalf. 2. Provide recent proof of income (e.g., federal tax return, social security award letter, bank statement, etc.). 3. Be available on occasion to work with PAS to finalize the applications (e.g., provide signatures, confirm information) and respond to follow-up requests from the various programs.
We’re here to help! Call us at any time with questions or concerns about your financial situation.
PAS REPRESENTATIVE: 866.744.8766 (toll free)
The Compassion to Care. The Knowledge to Heal. 2730 University W. Blvd., Suite 400 • Silver Spring, MD 20902 • 301-942-9220 2101 Medical Park Drive, Suite 200 • Silver Spring, MD 20902 • 301-933-3216 7350 Van Dusen Road, Suite 370 • Laurel, MD 20707 • 301-982-9800 7525 Greenway Center Drive, Suite 205 • Greenbelt, MD 20770 • 301-982-9800
Entrusting your patients' care to Maryland Oncology Hematology is greatly appreciated.
BLADDER CANCER FACTS Bladder cancer incidence is about four times higher in men than in women. When found early, the chance of survival is greater. Since the 1980s, the survival rate has increased due to improved awareness and better treatments options.
Risk factors Smoking: Smoking is the greatest risk factor for bladder caner; damaging chemicals from tobacco can enter the blood stream, through the lungs, and are filtered by the liver and collect in the bladder Chemical exposure: Some professions are regularly exposed to harmful chemicals which can lead to increased risk Race: Caucasians are twice more likely to develop bladder cancer than African Americans or Hispanics Gender: Men develop bladder cancer four times as often as women Age: The risk of developing bladder cancer increases with age Family history: There is an increased risk when immediate family members have the disease Chronic bladder inflammation: Urinary infections, kidney stones and bladder stones do not cause cancer, but they are linked to the disease Arsenic: This chemical in drinking water is linked to an increased risk of bladder cancer
Signs and symptoms If a patient experiences any of these symptoms they should consult a physician. Blood in urine Frequent urination or feeling the need to urinate
Screening Screening tests can determine the presence of abnormal cells in the bladder. There are various ways to screen for bladder cancer. Each method may be used alone, or in combination: Cystoscopy, which allows a physician to view the inside of the bladder through a small tube with a lens and a light; the physician may perform a biopsy at this time Urine cytology, which tests the urine or cells â&#x20AC;&#x153;washedâ&#x20AC;? from the bladder Urine culture, which involves testing the urine Imaging tests, which allows the doctors to better see your bladder and provide more information
Treatment If abnormal cells are present, the patient will be referred to an oncologist who will conduct a biopsy and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more
For more information, visit MDOnc.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.
LEUKEMIA CANCER FACTS
Leukemia is a cancer of the bone marrow and blood and is classified into four main groups according to cell type and rate of growth. Almost 90% of leukemia cases are diagnosed in adults 20 years of age and older.
Risk factors Radiation exposure: Exposure to ionizing radiation increases the risk of leukemia Family history: There is an increased risk when immediate family members have the disease Age: The majority is found in adults over the age of 20 Chemical exposure: Exposure to certain chemicals can increase the chances of developing leukemia Gender: Leukemia is more common in men than women
Signs and symptoms If a patient experiences any of these symptoms they should consult a physician. Fatigue or tiring more easily Fever Bruising easily Weight Loss Swollen belly Night sweats
Screening To diagnose and classify leukemia, a physician may conduct the following: Blood tests allow a physician to review the number of blood and/or marrow cells and look at the shape of chromosomes Bone marrow biopsy allows physicians to screen for abnormal cells
Treatment If cancer is suspected, the patient will be referred to an oncologist who will conduct tests and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more
For more information, visit MDOnc.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.
NON-HODGKIN LYMPHOMA CANCER FACTS Lymphoma is cancer of the lymphocytes, a type of white blood cell. There has been a decline in the number of deaths resulting from lymphoma due to improvements in treatment options.
Risk factors Age: The majority is found in adults over the age of 60 Chemical exposure: Exposure to certain chemicals can increase the chances of developing lymphoma Gender: Men are more likely to develop lymphoma than women Race: Caucasian individuals have greater incidence and death rates Immune system deficiency: Individuals with weakened immune systems are at increased risk
Signs and symptoms If a patient experiences any of these symptoms they should consult a physician. Swollen lymph nodes Itching Night sweats Fatigue or tiring more easily Swollen belly
Screening To diagnose lymphoma, a physician may conduct the following biopsies: Excisional or incisional biopsy allows a physician to determine the exact type of lymphoma by examining a sample removed from the patient Bone marrow biopsy allows a physician to withdraw a small amount of tissue using a thin, hollow needle
Treatment If cancer is suspected, the patient will be referred to an oncologist who will conduct tests and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more
For more information, visit MDOnc.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.
OVARIAN CANCER FACTS According to the American Cancer Society, ovarian cancer accounts for approximately 3% of all cancers among women. While incidence rates continue to decline, the disease usually has no obvious symptoms.
Risk factors Family history: The most important risk factor is strong family history of breast or ovarian cancer Age: Most ovarian cancers develop after menopause and half are found in women over the age of 63 Obesity: A higher rate of death from ovarian cancer is found in obese women Reproductive history: Women who began menstruating before 12, had no children or had their first child after 30, and/or experienced menopause after 50 may have an increased risk Fertility drugs: Prolonged use of the fertility drug clomiphene citrate, especially without achieving pregnancy, may increase risk Breast cancer: Women with BRCA mutation have an increased risk
Signs and symptoms The signs of ovarian cancer are usually relatively vague, including: Abnormal swelling of the stomach Unusual vaginal bleeding Pelvic pressure Pain in the back or legs Digestive problems such as gas, bloating, indigestion, long term stomach pain or feeling full quickly Having to urinate often or feeling like you have to â&#x20AC;&#x153;goâ&#x20AC;? right away
Screening Research is being done to develop a screening test for ovarian cancer, but currently no standard exists. However, there are tests that might be helpful to some women. For example, women with strong family history of the disease may be screened with transvaginal sonography and blood tests.
Treatment If a woman is suspected to have ovarian cancer, her physician may refer her to an oncologist for additional testing. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more
For more information, visit MDOnc.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.
PROSTATE CANCER FACTS
Prostate cancer is the second leading cause of cancer death for men in the United States. However, early detection can significantly improve the chances of survival.
Risk factors Age: The majority is found in men over the age of 65 Family history: There is an increased risk when immediate family members have the disease Diet: A diet including a lot of red meat and/or high-fat dairy products can yield a greater risk Exercise: Men who do not regularly exercise may have increased risk Race: African American men have greater incidence and death rates Nationality: Prostate cancer occurs more in North America
Signs and symptoms Usually, the early stages of prostate cancer are without obvious symptoms. However, any of the symptoms listed below should be discussed with a physician. Impotence Blood in urine Pain in the spine, hips, ribs or other bones Weakness or numbness in the legs or feet Loss of bladder or bowel control
Screening Screening tests can determine the presence of abnormal cells in the prostate. Beginning at age 50, men should have yearly screening exams, which include: Prostate-Specific Antigen (PSA) test, which screens blood for traces of PSA Digital Rectal Exam (DRE), which allows a doctor to physically examine the prostate for any lumps or hard places
Treatment If abnormal cells are present, the patient will be referred to an oncologist who will conduct a biopsy and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more
For more information, visit MDOnc.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.
BREAST CANCER FACTS Breast cancer is a malignant tumor that develops from cells in the breast. It is the second leading cause of cancer death among women in the United States.
Risk factors Age: Most breast cancers develop in adults over the age of 50 Family history: The chance of developing breast cancer increases when immediate family members have had the disease Personal history: Women who had cancer in one breast have an increased risk of developing cancer in another area of that same breast or in the other breast Reproductive history: Women who began menstruating before 12 or experienced menopause after 55 may have an increased risk Alcohol: Consumption of alcohol can slightly increase a womanâ&#x20AC;&#x2122;s chance of developing breast cancer Weight: Being overweight is linked to a higher risk of breast cancer
Signs and symptoms Patients experiencing any of these symptoms should consult a physician. Abnormal swelling of a part of the breast Skin irritation or dimpling Nipple pain, nipple turning inward or abnormal discharge Redness or scaliness of the nipple or breast skin Lump in the underarm
Screening To diagnose and classify breast cancer, a physician may conduct the following screenings to improve the chances that the disease can be found and treated successfully at an early stage: Mammograms, which should be performed each year for women age 40 and older Clinical breast exams, women in their 20s and 30s should have a clinical breast exam every 3 years, and women over the age of 40 should have the exam every year
Treatment If cancer is suspected, the patient will be referred to an oncologist who will conduct tests and determine the appropriate treatment plan. Our practice recognizes the importance of comprehensive care close to home. We provide: Comprehensive care, provided by board-certified oncologists and experienced nurses and support staff Precise radiation treatment, using leading-edge technology which provides fewer side effects Systemic therapies, including chemotherapy, biologic, hormone, immunotherapy and bone-targeting treatments Innovative clinical trials, providing the latest therapies through affiliations with The US Oncology Network, US Oncology Research and The Radiation Therapy Oncology Group On-site support services, such as patient navigation, counseling, charitable assistance, nutrition planning and more
For more information, visit MDOnc.com
The US Oncology Network is supported by McKesson Specialty Health. Š 2013 McKesson Specialty Health. All rights reserved.
Columbia
10710 Charter Drive, Suite G020 Columbia, MD 21044 Phone: 410-964-2212
Owings Mills
23 Crossroads, Suite 340 Owings Mills, MD 21117 Phone: 410-581-2100 Fax: 410-581-2104
Silver Spring
2101 Medical Park Drive Silver Spring, MD 20902 Phone: 301-933-3216
Help Us Know Your Medications A Personal Pocket Medication Card
Owings Mills & Gettysburg Mohit Narang, M.D. Robert L. Rice, M.D., Ph.D Silver Spring Kashif Ali, M.D. Alida Espinoza, M.D. Kashif Firozvi, M.D. Frederick Min, M.D.
Greenbelt
7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800
Laurel
7350 Van Dusen Road, Suite 370 Laurel, MD 20707 Phone: 301-982-9800
Greenbelt Thomas A. Bensinger, M.D., F.A.C.P. Martin D. Weltz, D.O., F.A.C.P., M.B.A., M.P.H
Gettysburg
40 V Twin Dr., Suite 104 Gettysburg, PA 17325 Phone: 717-338-9009 Fax: 717-334-1514
Columbia Jon K. Minford, M.D. Nicholas W. Koutrelakos, M.D. Clement B. Knight, M.D., MRCP, MRCPath Edward J. Lee, M.D. Tejaswi R. Sastry M.D. Adam Schmuckler, P.A.-C., MMSc
www.mdonc.com
Laurel Thomas A. Bensinger, M.D., F.A.C.P. Martin D. Weltz, D.O., F.A.C.P., M.B.A., M.P.H
Patient Information Name Phone Allergies
Primary/Family Physician Name Phone
Pharmacy Name Phone
Specialist Name Phone
Drug Name/Reason For Use
Dosage/Strength
How Often/Times Taken
Over the Counter Medications/ Vitamins/Herbals
Review with your doctor and pharmacist • Keep an up to date list of medications • Keep with you at all times • Reduces confusion and saves time • Improves MEDICATION SAFETY
Maryland Oncology Hematology
Kashif Ali, M.D. Dr. Kashif Ali earned his MD Degree from Ross University School of Medicine. He completed his residency in Internal Medicine at the Seton Hall University in New Jersey. While at Seton Hall University he became the Chief Resident and then went on to complete his training in Hematology and Oncology. During this training he was appointed Chief Fellow. Dr. Ali is presently board certified in Internal Medicine, Hematology and Oncology. Dr. Ali is available to see patients in Hematology and Oncology.
Dr. Aliâ&#x20AC;&#x2122;s office locations: Laurel
Silver Spring
7350 Van Dusen Road, Suite 370
2101 Medical Park Drive, Suite 200
Laurel, MD 20707
Silver Spring, MD 20902
Phone: 301-982-9800
Phone: 301-933-3216
Greenbelt 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800 For more information, please visit www.MDOnc.com.
The Knowledge to Heal. The Compassion to Care.
IS CANCER IN YOUR GENES? Find out if you are at an increased risk for cancer.
Hereditary Cancer Risk and Assessment Program What is genetic testing? Today, tests are available that will find some cancer-related genes in the human body. Gene testing can determine if you have or do not have a disease-related gene condition that may put you at higher risk of getting cancer before any symptoms appear.
Who should consider genetic counseling/testing? Some people are at higher risk of developing certain types of cancer because they have an inherited gene condition. If you have been diagnosed with cancer before the age 50, have multiple family members with the same type of cancer or have experienced multiple cancers, you may want to speak with your physician about genetic counseling.
Why is genetic testing important? Although genetic testing cannot predict whether you will actually develop cancer, understanding your risk of developing the disease can be an important step in making lifestyle decisions that can help prevent cancer or about getting regular screenings that can detect cancer early, when it is most treatable.
Consider scheduling an appointment with Maryland Oncology Hematology if you or a family member have: Breast Cancer under age 50 Bilateral Breast Cancer Ovarian Cancer at any age Male breast cancer in patient or family member Ashkenazi Jewish Ancestry with Personal or Family History of Breast and/or Ovarian Cancer
More than 3 Family Members with Breast and/or Ovarian Cancer
More than 2 Family Members with Premenopausal
Breast and/or Ovarian Cancer at any age
About the Hereditary Risk and Assessment Program As part of our comprehensive cancer care services, Maryland Oncology Hematology provides an in-depth cancer risk assessment for individuals with a significant personal and/or family history of cancer. Our physicians provide information and support to patients
Call to schedule an appointment:
and their families by:
• educating you about how genetics plays a part in cancer risk;
COLUMBIA (410) 964-2212
• assessing your risk of a genetic disorder by researching your family’s history and evaluating medical records;
• discussing the medical, social and ethical impact of genetic testing on you and your family;
• interpreting genetic testing results and medical data; and • explaining possible treatments or preventive measures. 10710 Charter Drive, Suite G020 • Columbia, MD 21044 Learn more at
mdonc.com
Comprehensive care close to home. Services Every cancer is different, and so is every person. That’s why we offer a full range of treatments and support services that can be tailored to your individual needs. Most cancer treatments do not require hospitalization, and can be performed in our outpatient infusion room. Maryland Oncology’s state-of-the-art facilities, staffed by experience physicians and specially trained oncology nurses, provide injections, infusions, chemotherapy, antibiotics and other medication to patients in a comfortable and friendly setting. • Physician evaluation and treatment planning for blood disorders and cancer care • Chemotherapy and infusion therapy • Administration of injections for the treatment of cancer and hematologic disorders • Therapeutic phlebotomies • Laboratory services by a state accredited lab
Clinton
8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911
Physicians and Services
Columbia
10710 Charter Drive, Suite G020 Columbia, MD 21044 410-964-2212
Since 1986, Maryland Oncology Hematology has made important contributions to the fight against cancer and diseases of the blood by offering a full range of treatment options and support services, as well as clinical research trials to our patients and their families. Maryland Oncology Hematology also provides access to resources typically found only in major academic medical centers and large hospital systems, along with the personal touch and compassion that you would expect to find from your community physician. And because of our integrated, team-based approach to patient care, we work closely with our patients and their families to create an individual treatment plan that cares for their physical and emotional health. Best of all, this entire comprehensive plan is delivered in a familiar setting, close to home.
Greenbelt
7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 301-982-9800
Lanham
8116 Good Luck Road, Suite100 Lanham, MD 20706 301-474-0427
Laurel
7350 Van Dusen Road, Suite 370 Laurel, MD 20707 301-982-9800
Sliver Spring
12210 Plum Orchard Drive, Suite 211 Silver Spring, MD 20904 301-933-3216
Wheaton
2730 University W Blvd., Suite 400 Wheaton, MD 20902 301-942-9220
Maryland Oncology Hematology is an affiliate of The US Oncology Network, one of the nation’s
• Bone marrow biopsies
largest community-based cancer treatment and
• Maintenance of IV devices
research networks focused on advancing cancer
• Access to complementary and alternative medicine
care in America. As an affiliate of The US Oncology Network, Maryland Oncology Hematology is united with approximately 1,000 physicians
• Second opinion services
mdonc.com
The Knowledge to Heal. The Compassion to Care.
nationwide. Maryland Oncology Hematology
participates in clinical trials through US Oncology Research, which has helped to develop 48 FDA approved cancer therapies.
Medical O ncology & Hematology Kashif Ali, M.D.
Medical School: Ross University School of Medicine Residency: Seton Hall University Fellowship: Seton Hall University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Silver Spring and Laurel
Kashif Firozvi, M.D.
Medical School: Georgetown University School of Medicine Residency: Georgetown School of Medicine Fellowship: Georgetownâ&#x20AC;&#x2122;s Lombardi Cancer Center Board Certifications: Medical Oncology Location: Silver Spring
Edward J. Lee, M.D.
Jun Sun, M.D.
Medical School: State University of New York Downstate Medical College Residency: Baltimore City Hospital Fellowship: University of Maryland Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia
Medical School: State University of New York at Buffalo School of Medicine Residency: Georgetown University Hospital Fellowship: Georgetown University Hospital/ Lombardi Cancer Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Cheryl A. Aylesworth, M.D.
Ari D. Fishman, M.D.
Jose Mendoza, M.D., F.A.C.P.
Deepnarayan Tiwarri, M.D.
Thomas A. Bensinger, M.D., F.A.C.P.
Rita Gupta, M.D., F.A.C.P.
Frederick Min, M.D.
Nikolaos Trikalinos, M.D.
Linda M. Burrell, M.D.
David J. Haidak, M.D., F.A.C.P.
Jon K. Minford, M.D.
Medical School: Tufts University School of Medicine Residency: Walter Reed Army Medical Center Fellowship: Walter Reed Army Medical Center Board Certifications: Internal Medicine and Medical Oncology Location: Wheaton
Medical School: George Washington School of Medicine Residency: Walter Reed Army Medical Center Fellowship: Duke University Medical Center and City of Hope National Medical Center Board Certifications: Internal Medicine and Hematology Location: Greenbelt Medical School: State University of New York Upstate Medical Center Residency: Walter Reed Army Medical Center Fellowship: Walter Reed Army Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Wheaton
Nicholas A. DeMonaco, M.D.
Medical School: Temple University School of Medicine Residency: University of Pittsburgh Fellowship: University of Pittsburgh Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Alida Espinoza, M.D.
Medical School: Central University of Venezuela Residency: Union Memorial Hospital Fellowship: University of Maryland Greenebaum Cancer Center Board Certification: Medical Oncology Locations: Silver Spring and Greenbelt
Medical School: Tel Aviv University Residency: Albert Einstein College of Medicine Fellowship: Montefiore Medical Center, Albert Einstein Comprehensive Cancer Center at Albert Einstein College of Medicine Board Certification: Internal Medicine, Medical Oncology and Hematology Locations: Wheaton and Greenbelt Medical School: Gandhi Medical College of Bhopal University Residency: Prince George Hospital Center Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Medical School: Albany Medical College Residency: Georgetown University Hospital and D.C. General Hospital Fellowship: Georgetown University Hospital and George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology, and Hematology Locations: Clinton and Lanham
Medical School: San Marcos National Major University Medical School Residency: The Washington Hospital Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Medical School: Cornell Residency: Cornell Fellowship: NIH and Georgetown University Medical Center Board Certifications: Internal Medicine and Medical Oncology Location: Silver Spring
Medical School: University of Pittsburgh School of Medicine Residency: New York University Medical Center Fellowship: National Cancer Institute Board Certifications: Internal Medicine and Medical Oncology Location: Columbia
Harvey I. Katzen, M.D., F.A.C.P.
Mohit Narang, M.D.
Nicholas W. Koutrelakos, M.D.
Tejaswi R. Sastry, M.D.
Medical School: George Washington Medical Center Residency: George Washington University Hospital Fellowship: George Washington University Hospital Board Certifications: Internal Medicine and Medical Oncology Locations: Clinton and Lanham
Medical School: University of Maryland Residency: University of Massachusetts, Berkshire Medical School Fellowship: Brown University Board Certifications: Medical Oncology Location: Columbia
Medical School: Dayanand Medical College Residency: Christ Hospital Fellowship: Michigan State University Board Certifications: Internal Medicine and Medical Oncology Locations: Columbia
Medical School: Kempegowda Institute of Medical Services Residency: University of North Carolina at Chapel Hill, Moses Cone Health Systems Fellowship: Eastern Carolina University Brody School of Medicine Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia
Medical School: Howard University College of Medicine Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Medical School: University of Ioannina Medical School Residency: MetroWest Medical Center Fellowship: University of Marylandâ&#x20AC;&#x2122;s Greenebaum Cancer Center Board Certification: Internal Medicine Locations: Clinton and Lanham
P hysician Extenders Adam Schmuckler, P.A.-C., MMSc College: Syracuse University Graduate School: Emory University Location: Columbia
Kristin Sorensen, FNP-C
College: Syracuse University Graduate School: University of Maryland Location: Silver Spring
WE ARE MAKING A CHANGE
New name. Same great care. Dr. Ari Fishman is joining the highly skilled physician team of Maryland Oncology Hematology to provide patients high-quality cancer care closer to home. Maryland Oncology Hematology, is committed to providing convenient, compassionate and cutting-edge hematology and oncology care to patients in our community. Dr. Fishman will be practicing at Maryland Oncology Hematologyâ&#x20AC;&#x2122;s Silver Spring and Greenbelt locations.
Please ask your care provider or the front desk for more information on this exciting news.
Maryland Oncology Hematology UPDATE Summer 2013
OUR PHYSICIANS Kashif Ali, M.D. Manoj Agarwal, M.D., M.B.A. Cheryl Aylesworth, M.D. Thomas A. Bensinger M.D., F.A.C.P. Linda Burrell, M.D. Roopa De Chowdhury, M.D. Nicholas A. DeMonaco M.D. Alida Espinoza, M.D. Kashif Firozvi, M.D. Rita Gupta, M.D., F.A.C.P. David J. Haidak, M.D., F.A.C.P. Harvey I. Katzen, M.D., F.A.C.P. Nicholas W. Koutrelakos, M.D. Edward J. Lee, M.D. Jose Mendoza, M.D., F.A.C.P. Frederick Min, M.D. Jon K. Minford, M.D. Mohit Narang, M.D. Robert L. Rice, M.D., Ph.D. Tejaswi R. Sastry M.D. Jun Sun, M.D. Deepnarayan Tiwarri, M.D. Kai-Yiu Yeung, M.D., F.A.C.P. Ayana Elliott DNP, MS, APRN, F.N.P.-C. Adam Schmuckler P.A.-C., MMSc Kristin Sorensen N.P.-C., MS, R.N.
Oncology-Hematology Associates and Maryland Oncology Hematology Unite to Provide Expanded Quality Care Maryland Oncology Hematology is pleased to announce that Oncology-Hematology Associates, P.A. has joined its practice, expanding and enhancing patient services as well as adding additional treatment locations in Clinton and Lanham, MD. The eight board-certified physicians of Oncology-Hematology Associates joined Maryland Oncology Hematology’s group of 15 oncologists to offer state-of-the-art, comprehensive cancer care to oncology and hematology patients in the comfort and convenience of a patient-centered community setting. “We are pleased to welcome the physicians of Oncology-Hematology Associates to our practice,” said Jon Minford, M.D., medical oncologist and founder of Maryland Oncology Hematology. “Our collaboration with this team of like-minded, highly trained cancer specialists will allow us to expand and enhance our treatment model of providing high quality integrated, evidence-based cancer care and clinical research. Additionally, our patients will now have access to care in two more convenient locations in Maryland.” Together, Oncology-Hematology Associates and Maryland Oncology Hematology provide expanded service offerings to Clinton and Lanham, MD with the addition of Drs. David J. Haidak, Kai-Yiu Yeung, Harvey I. Katzen, Rita Gupta, Deepnarayan Tiwarri, Nicholas A. DeMonaco, Jose L. Mendoza and Jun F. Sun. Featured physicians left to right: Top Row Dr. DeMonaco, Dr. Sun, Dr. Katzen, Dr. Tiwarri Bottom Row Dr. Mendoza, Dr. Haidak, Dr. Yeung, Dr. Gupta
mdonc.com
Meet Our New Physician Team Members NICHOLAS A. DEMONACO M.D. Medical School: Temple University School of Medicine
OUR LOCATIONS
Residency: University of Pittsburgh
CLINTON 8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911
Board Certifications: Internal Medicine, Medical Oncology and Hematology
Fellowship: University of Pittsburgh
Locations: Clinton and Lanham
RITA GUPTA, M.D., F.A.C.P. Medical School: Gandhi Medical College of Bhopal University Residency: Prince George Hospital Center Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
COLUMBIA 10710 Charter Drive, Suite G020 Columbia, Maryland 21044 410-964-2212
DAVID J. HAIDAK, M.D., F.A.C.P.
HARVEY I. KATZEN, M.D., F.A.C.P.
Medical School: Albany Medical College
Medical School: George Washington Medical Center
GETTYSBURG 40 V Twin Drive, Suite 104 Gettysburg, PA 17325 717-338-9009
Residency: Georgetown University Hospital and D.C. General Hospital
Residency: George Washington University Hospital
Fellowship: Georgetown University Hospital and George Washington University Medical Center
Fellowship: George Washington University
GREENBELT 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 301-982-9800
Board Certifications: Internal Medicine, Medical Oncology and Hematology
Board Certifications: Internal Medicine and Medical Oncology
Locations: Clinton and Lanham
Locations: Clinton and Lanham
LANHAM 8116 Good Luck Road, Suite100 Lanham, MD 20706 301-474-0427 LAUREL 7350 Van Dusen Road, Suite 370 Laurel, MD 20707 301-982-9800 PIKESVILLE 1838 Greene Tree Road, Suite 260 Pikesvlle, MD 21208 410-581-2100
JOSE MENDOZA, M.D F.A.C.P. Medical School: San Marcos National Major University Medical School Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
SILVER SPRING 2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902 301-933-3216 WESTMINSTER 680 Poole Road, Suites A & B Westminster, MD 21157 410-581-2100 WHEATON 2730 University W Blvd., Suite 400 Wheaton, MD 20902 301-924-9220
Hospital
JUN SUN, M.D. Medical School: State University of New York at Buffalo School of Medicine Residency: Georgetown University Medical Center Fellowship: Georgetown Universityâ&#x20AC;&#x2122;s Lombardi Cancer Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
DEEPNARAYAN TIWARRI, M.D.
KAI-YIU YEUNG, M.D., F.A.C.P.
Medical School: Howard University College of Medicine
Medical School: National Taiwan University College of Medicine
Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Residency: Veterans Administration Hospital Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Maryland Oncology Hematology UPDATE Summer 2013
Kashif Ali, M.D.
Linda M. Burrell M.D.
Kashif Firozvi M.D.
Nicholas W. Koutrelakos, M.D.
Jon K. Minford M.D.
Jun Sun, M.D.
Manoj Agarwal M.D., M.B.A.
Roopa De Chowdhury, M.D.
Rita Gupta M.D., F.A.C.P.
Edward J. Lee M.D.
Mohit Narang M.D.
Deepnarayan Tiwarri, M.D.
Cheryl A. Aylesworth, M.D.
Nicholas A. DeMonaco M.D.
David J. Haidak M.D., F.A.C.P.
Jose Mendoza M.D., F.A.C.P.
Robert L. Rice M.D., Ph.D
Kai-Yiu Yeung M.D., F.A.C.P.
Thomas A. Bensinger M.D., F.A.C.P.
Alida Espinoza M.D.
Harvey I. Katzen M.D., F.A.C.P.
Frederick Min M.D.
Tejaswi R. Sastry M.D.
mdonc.com
2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902
UNITED Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest community-based cancer treatment and research networks dedicated to advancing cancer care and expanding patient access to high-quality care.
WE HEAL mdonc.com
Patient Binder
2101 Medical Park Drive, Suite 200 Silver Spring, MD 21044 Phone (301) 933-3216 Fax (301) 933-4941 www.mdonc.com
Kashif A. Firozvi, MD • Fredrick Min, MD • Alida Andriollo Espinoza, MD • Kashif Ali, MD • Kristin Sorensen-Tanenbaum, NP
PATIENT PLANNER B A S I C S F OR T HE N E WLY DIAGNOSE D
A PLANNER FOR PEOPLE WITH CANCER AND THEIR CAREGIVERS
www.MD ONC.c o m
Clinton 8926 Woodyard Road Suite 101 Clinton, MD 20735 Phone: 301-868-7911
Columbia 10710 Charter Drive Suite G020 Columbia, MD 21044 Phone: 410-964-2212
Gettysburg 40 V Twin Dr. Suite 104 Gettysburg, PA 17325 Phone: 717-338-9009
Greenbelt 7525 Greenway Center Dr. Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800
Lanham 8116 Good Luck Road Suite 100 Lanham, MD 20706 Phone: 301-474-0427
Laurel 7350 Van Dusen Road Suite 370 Laurel, MD 20707 Phone: 301-982-9800
Silver Spring 2101 Medical Park Drive Silver Spring, MD 20902 Phone: 301-933-3216
Wheaton 2730 University W. Blvd. Suite 400 Wheaton, MD 20902 Phone: 301-942-9220
Our mission is to deliver on the promise of providing the best patient care possible in a caring and supportive environment; with seamless access to the latest in technology and research available to help every patient live their highest quality of life.
OUR PHYSICIANS COLUMBIA Jon K. Minford, MD Nicholas W. Koutrelakos, MD Edward J. Lee, MD Mohit Narang, MD Tejaswi R. Sastry, MD
SILVER SPRING
Kashif Firozvi, MD Frederick Min, MD Alida Espinoza, MD Kashif Ali, MD Roopa DeChowdhury, MD
GREENBELT & LAUREL
PROVIDING COMPREHENSIVE, COMPASSIONATE CARE. Maryland Oncology Hematology provides patients with cutting-edge treatment options by a specialized team of board certified physicians. Our physicians have been recognized as Top Doctors by Baltimore Magazine, Washingtonian Magazine, and the US News & World Report. Our state of the art infusion centers offer services such as chemotherapy, laboratory testing, clinical trials and supportive care. The dedicated staff provide a full range of cancer care services.
For more information: www.mdonc.com
Thomas A. Bensinger, MD, FACP Alida Espinoza, MD Kashif Ali, MD Roopa DeChowdhury, MD
GETTYSBURG
Robert Rice, MD, PhD Mohit Narang, MD
CLINTON/LANHAM
David J. Haidak, MD, FACP Kai-Yiu Yeung, MD, FACP Harvey I. Katzen, MD, FACP Rita Gupta, MD, FACP Deepnarayan Tiwarri, MD Nicholas A. DeMonaco, MD Jun F. Sun, MD
WHEATON
Cheryl Aylesworth, MD Linda Burrell, MD
COLUMBIA (410) 964-2212
SILVER SPRING (301) 933-3216
GREENBELT (301) 982-9800
LAUREL (301) 982-9800
GETTYSBURG (717) 338-9009
WHEATON (301) 942-9220
CLINTON (301) 868-7911
LANHAM (301) 474-0427
1_13080996 VER31 MOH.indd 1
9/25/13 11:10 AM
TH E K N O W LE DGE T O HE AL . T H E C O M PA S S ION T O C A R E . Providing comprehensive, compassionate care to people challenged by cancer and blood disorders in the Prince Georgeâ&#x20AC;&#x2122;s County area. David Haidak, MD, FACP Harvey Katzen, MD, FACP Rita Gupta, MD, FACP Deepnarayan Tiwarri, MD Nicholas DeMonaco, MD Jun Sun, MD Nikolaos Trikalinos M.D.
Clinton 8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911 Lanham 8116 Good Luck Road, Suite 100 Lanham, MD 20706 301-474-0427
mdonc.com
Joining Forces in the Fight.
Maryland Oncology Hematology is pleased to announce the addition of Ari Fishman, M.D. to our physician staff.
E x p e rt P h y s i c i a n s . Exceptional Care.
At Maryland Oncology Hematology, we believe the best care is both advanced and compassionate. Our philosophy is to care for the whole person, not just fight the disease. We are proud to welcome Dr. Ari Fishman to our team of board certified physicians. Together, we will continue to provide patients with the latest cutting-edge treatments and options in their fight against cancer. Together with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest community-based cancer treatment and research networks, Maryland Oncology Hematology is dedicated to expanding patient access to high-quality care. Dr. Fishman will see patients at our Greenbelt and Silver Spring Locations: GREENBELT 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800 SILVER SPRING 2730 University W. Blvd, Suite 400 Silver Spring, MD 20902 Phone: 301-942-9220 (Two Blocks from Wheaton Metro Station - Red Line)
Ari Fishman, M.D.
2730 University W. Blvd, Suite 400 Silver Spring, MD 20902
Joining Forces in the Fight.
Maryland Oncology Hematology is pleased to announce the addition of Ari Fishman, M.D. to our physician staff.
E x p e rt P h y s i c i a n s .E x c e p t i o n a l C a r e . At Maryland Oncology Hematology, we believe the best care is both advanced and compassionate. Our philosophy is to care for the whole person, not just fight the disease. We are proud to welcome Dr. Ari Fishman to our team of board certified physicians. Together, we will continue to provide patients with the latest cutting-edge treatments and options in their fight against cancer. Together with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest community-based cancer treatment and research networks, Maryland Oncology Hematology is dedicated to expanding patient access to high-quality care. Dr. Fishman will see patients at our Greenbelt and Silver Spring Locations: GREENBELT 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 Phone: 301-982-9800
SILVER SPRING 2730 University W. Blvd, Suite 400 Silver Spring, MD 20902 Phone: 301-942-9220 (Two Blocks from Wheaton Metro Station - Red Line)
Ari Fishman, M.D.
Rockville
South Laurel
Silver Spring Potomac
Greenbelt
495
McLean
Columbia Heights
WASHINGTON Capitol Heights
Arlington Annandale
395
295
Alexandria 95
Suitland-Silver Hill
WE ARE PROUD TO ANNOUNCE OUR NEW
LOCATION
12210 Plum Orchard Dr., Suite 211
Silver Spring, MD 20904
12210 Plum Orchard Dr., Suite 211 | Silver Spring, MD 20904
Brain Cancer Facts Primary brain tumors can start in almost any type of tissue or cell in the brain or spinal cord. Unlike cancers that start in other parts of the body, tumors that start in the brain or spinal cord rarely spread to distant organs, instead they cause damage by growing and destroying normal brain tissue. In 2013, about 23,130 malignant tumors of the brain or spinal cord are expected to be diagnosed in the United States. Overall, the chance that a person will develop a malignant tumor of the brain or spinal cord in his or her lifetime is less than 1% (about 1 in 140 for a man and 1 in 180 for a woman). Estimated New Brain Cancer Cases and Deaths 2007-2013 25,000 20,000 15,000 New Cases
10,000
Deaths
5,000 0
American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.
Risk Factors
Signs and Symptoms
There are several factors that may increase the likelihood of
Tumors in any part of the brain may cause the intracranial pressure
developing brain tumors including:
to rise. This can be caused by growth of the tumor itself, swelling
Radiation exposure : The best known environmental risk factor for
brain tumors is radiation exposure, most often from some type of radiation therapy.
in the brain, or a blockage in the flow of cerebrospinal fluid. This increased pressure can lead to symptoms such as: •
Headache
•
Nausea
to have many tumors that first occur when they are young.
•
Vomiting
Some of these families have well-defined disorders, such as
•
Blurred vision
Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2),
•
Balance problems
Tuberous sclerosis, Von Hippel-Lindau disease or Li-Fraumeni
•
Personality or behavior changes
•
Seizures
•
Drowsiness or even coma
Family history: Patients with familial cancer syndromes tend
syndrome. Immune system disorders: Patients with impaired immune systems
have an increased risk of developing lymphomas of the brain or spinal cord.
Sources: National Cancer Institute and American Cancer Society
www.MDOnc.com
Brain Cancer Facts Screening At this time there are no widely recommended tests used to screen for brain and spinal cord tumors. Most brain tumors are found when a person sees a doctor because of signs or symptoms they are experiencing. Doctors recommend, however, that patients with certain inherited syndromes that put them at higher risk for brain tumors, such as neurofibromatosis or tuberous sclerosis, obtain
THE KNOWLEDGE TO HEAL. THE COMPASSION TO CARE. For over 20 years, Maryland Oncology Hematology has provided comprehensive, compassionate care to patients facing cancer and blood disorders in the Maryland area. Our team of experienced physicians, oncology certified nurses, and staff guides patients and their families through the latest advancements in treatment
frequent physical exams and other tests beginning at a young age.
options. Maryland Oncology Hematology offers a full range of
Staging
trials and support services all conveniently located in a familiar
personalized chemotherapy services, laboratory testing, clinical community setting.
If cancer is found, a physician will need to determine the progression of the cancer. This classification, called staging, allows the healthcare provider to properly identify a treatment plan and to determine the prognosis. All cancers are staged on a roman numeral scale, of I-IV (1-4), where the higher stage represents more advanced cancer.
Cheryl Aylesworth, MD Thomas Bensinger, MD, FACP Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C
Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com
ESOPHAGEAL CANCER FACTS There are two main types of cancer of the esophagus. One type grows in the cells that form the inside layer of the lining of the esophagus. This cancer is called squamous cell carcinoma and accounts for less than half of all cancers of the esophagus. The other type starts in the gland cells and is called adenocarcinoma. About 17,990 new esophageal cancer cases were diagnosed in the last year and 15,210 deaths were attributed to the disease. Esophageal cancer is three to four times more common among men than women with the lifetime risk of developing esophageal cancer in the United States about 1 in 125 for men and about 1 in 435 for women.
20,000
Estimated New Esophageal Cancer Cases and Deaths 2007-2013
15,000 New Cases
10,000
Deaths
5,000 0
American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.
Risk Factors There are several factors that may increase the likelihood of developing esophageal cancer including: Age: The chance of developing esophageal cancer is low at younger
ages and increases with age. Less than 15 percent of cases are found in people younger than 55. Gender: Men have a three-fold higher risk of developing esophageal
cancer than women. Gastroesophageal reflux disease (GERD): Patients with GERD
have a higher risk of getting adenocarcinoma of the esophagus. The risk goes up based on how long GERD has been present and how severe the symptoms are. GERD can also cause Barrett’s esophagus, which is linked to an even higher risk. Barrett’s esophagus: Barrett’s esophagus increases the risk
of adenocarcinoma of the esophagus and the development of esophageal cancer. Tobacco and alcohol: The use of tobacco products, including
cigarettes, cigars, pipes, and chewing tobacco, is a significant risk
Sources: National Cancer Institute and American Cancer Society
factor for esophageal cancer, and the risk increases with increased use. Drinking alcohol also increases the risk of esophageal cancer, and combining smoking and drinking alcohol raises the risk of esophageal cancer much more than using either alone. Obesity: People who are overweight or obese have a higher chance of having esophageal reflex and getting adenocarcinoma of the esophagus. Diet: A diet high in processed meat, overeating and drinking very hot liquids frequently may increase the chance of developing esophageal cancer. A diet high in fruits and vegetables, however, is linked to a lower risk of esophageal cancer. Achalasia: Patients with achalasia have an increased risk of
esophageal cancer. On average, the cancer is often found 15-20 years after the achalasia is diagnosed. Tylosis: Patients with this rare, inherited disease have a very high
risk of getting squamous cell cancer of the esophagus and must be monitored closely for esophageal cancer.
www.MDOnc.com
ESOPHAGEAL CANCER FACTS Esophageal webs: About 1 in 10 patients with this syndrome eventually develop squamous cell cancer of the esophagus. Workplace exposures: Exposure to chemical fumes in certain
workplaces may lead to an increased risk of esophageal cancer. For example, exposure to the solvents used for dry cleaning may lead to a greater risk of esophageal cancer. Injury to the esophagus: Children who accidently swallow household cleaners containing lye and receive a severe chemical burn in the esophagus have an increased risk of developing squamous cell esophageal cancer as adults. History of certain other cancers: Patients who have had certain other cancers, such as lung cancer, mouth cancer, and throat cancer have a high risk of getting squamous cell carcinoma of the esophagus as well. Human papilloma virus: Genes from human papilloma virus (HPV)
have been found in up to one-third of esophagus cancer tumors from patients living in Asia and South Africa, but signs of HPV infection have not been found in esophagus cancers from patients living in the other areas, including the US.
Signs and Symptoms Esophageal cancers are usually found because of signs or symptoms a person is experiencing. If esophagus cancer is suspected, tests will be needed to confirm the diagnosis. Signs and symptoms of esophageal cancer include:
Screening In the United States, screening the general public for esophageal cancer is not recommended by any professional organization at this time, because no screening test has been shown to lower the risk of dying from esophageal cancer in people who are at average risk. However, people who have a high risk of esophageal cancer, such as those with Barrett’s esophagus, are often followed closely and have a regular upper endoscopy to look for early cancers and pre-cancers.
Staging If cancer is found, a physician will need to determine the progression of the cancer. This classification, called staging, allows the healthcare provider to properly identify a treatment plan and to determine the prognosis. All cancers are staged on a roman numeral scale, of I-IV (1-4), where the higher stage represents more advanced cancer.
Cheryl Aylesworth, MD Thomas Bensinger, MD, FACP Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD
•
Trouble swallowing
•
Chest pain
•
Weight loss
•
Hoarseness
•
Chronic cough
•
Hiccups
•
Pneumonia
•
Bone pain
•
Bleeding into the esophagus
Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C
Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com
Oral Cavity & Oropharyngeal Cancer AWARENESS Oral cavity cancer occurs when cancer cells form in the mouth. Orophayngeal cancer begins in the oropharynx, the portion of the throat just beyond the mouth, which includes the base of the tongue, the soft palate, tonsils and the side and back walls of the throat. The American Cancer Society estimates that 36,000 new cases of cancer of the oral cavity and pharynx will be diagnosed in 2013 and that 6,850 oral cancer related deaths are expected to occur. Estimated New Oral Cavity & Oropharyngeal Cancer Cases and Deaths 2007-2013 45,000 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0
New Cases Deaths
Data pulled from the American Cancer Society, Cancer Facts and Figures 2007 – 2013.
Risk Factors
Signs and Symptoms
Tobacco and Alcohol: Tobacco and alcohol use are the strongest
Oral cavity and oropharyngeal cancer may be discovered during an
risk factors for oral cavity and oropharyngeal cancers. Studies have
oral exam by dentist or doctor but is typically diagnosed as a result
estimated the risk of developing these cancers in heavy drinkers and
of symptoms occurring:
smokers may be as much as 100 times more than the risk of these
•
Mouth sore that won’t heal
•
A lump or thickening in cheeks
•
White or red patches on the gums, tongue, tonsils, or lining of the mouth
Gender: Men are twice as likely to develop oral or oropharyngeal
•
Trouble chewing or swallowing
cancer than women.
•
Tongue numbness
•
Voice changes
•
Difficulty moving the tongue or jaw
•
Bad breath that doesn’t go away
•
Swollen jaw
•
Loosening of the teeth
•
Pain around the teeth or jaw
•
Weight loss
cancers in people who don’t smoke or drink. Human papilloma virus (HPV) infection: Human papilloma virus
DNA is now linked to about 2 out of every 3 oropharyngeal cancers.
Age: Most diagnoses of oral and oropharyngeal cancers occur after
the age of 55. Genetic syndromes: Individuals with fanconi anemia or
dyskeratosis congenita are at increased risk for developing oral cancer.
Source: American Cancer Society
www.MDOnc.com
Oral Cavity & Oropharyngeal Cancer AWARENESS Screening There are various ways to screen for oral cavity or oropharyngeal cancer. Each method may be used alone, or in combination. Medical history and physical exam: Physician will ask about
symptoms related to oral cancer and check for possible signs. Complete head and neck exam: A specialist will do a thorough
examination of the head and neck area checking for abnormalities. The exam will utilize mirrors or fiber-optic scopes to observe the lymph nodes and deeper portions of the neck. Panendoscopy: This exam is performed in an operating room
THE KNOWLEDGE TO HEAL. THE COMPASSION TO CARE. For over 20 years, Maryland Oncology Hematology has provided comprehensive, compassionate care to patients facing cancer and blood disorders in the Maryland area. Our team of experienced physicians, oncology certified nurses, and staff guides patients and their families through the latest advancements in treatment options. Maryland Oncology Hematology offers a full range of personalized chemotherapy services, laboratory testing, clinical trials and support services all conveniently located in a familiar community setting.
while the patient is under general anesthesia by using various types of endoscopes to examine the oral cavity, oropharynx, larynx, esophagus, trachea and bronchi. Biopsy: Tissue samples are observed under a microscope. Imaging tests: Allow for more detailed examination of the mouth
and throat.
Treatment There are many treatment options for oral cancer, including chemotherapy, radiation therapy and surgery. Each method may
Cheryl Aylesworth, MD Thomas Bensinger, MD, FACP Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C
be used alone, or in combination. Chemotherapy is the use of drugs to kill cancer cells. The
drugs are administered orally by pills or injected directly into the bloodstream. They travel throughout the body to reach cancer cells that may have spread beyond the point of origin. Radiation therapy is the use of high-energy rays to kill cancer
cells in the treatment area. It is mostly administered externally from a machine outside the body, similar to an x-ray, but for a longer period of time. Surgery treats the cancer by removing the cancerous tissue. The
type of surgery required depends on the stage of the cancer.
Staging If cancer is found, a physician will need to determine the progression of the cancer. This classification, called staging, allows the healthcare provider to properly identify a treatment plan and to determine the prognosis. All cancers are staged on a roman numeral scale, of I-IV (1-4), where the higher stage represents more advanced cancer.
Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com
SKIN Cancer FACTS People say the glow of a tan makes them look healthier, but tanning is actually the skin’s reaction to harmful UV ray exposure. Skin cancer is the most common form of cancer in the United States. In fact, it is estimated by the American Cancer Society that more than two million cases of skin cancer will be diagnosed this year. Indoor tanning is especially dangerous causing a 74% increased risk for melanoma, compared to those who have never used a tanning bed.1 There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Both basal cell and squamous cell carcinoma are highly treatable. Malignant melanoma is the most serious type of skin cancer and more likely to spread to other parts of the body.
Risk Factors
Signs and Symptoms
Exposure to sunlight: Exposure to UV radiation, either from the
Patients should check the pattern of moles, freckles and other marks
sun or tanning lamps increases risk for melanoma.
once a month and consult their healthcare provider if a mole or
Fair skin: People with fair skin, freckling or red or blond hair have a higher risk of melanoma.
growth worries them or has changed in size, shape or color. The ABCD rule can help distinguish a normal mole from melanoma:
Age: Chances of being diagnosed with skin cancer increase with age,
Asymmetry: One half of the mole does not match the other half. Border irregularity: The edges of the mole are ragged or notched. Color: The color of the mole is not the same all over. There may be
but skin cancer is also found in young people.
shades of tan, brown or black and sometimes patches of red,
Moles: Certain types of moles increase a person’s chance of getting melanoma.
Family history: Around 10 percent of people with melanoma have a close relative with the disease. This may be because the family tends to spend more time in the sun or because family members have
white or blue.
Diameter: The mole is wider than about ¼ inch.
fair skin, or both.
diagnosis
Immune suppression: People who have been treated with
If cancer is suspected, a physician will perform further tests, which
medicines that suppress the immune system have an increased chance
may include a skin biopsy. Types of skin biopsies include:
of developing melanoma.
Incisional and excisional biopsies remove a wedge of the skin
History of melanoma: People who have already had melanoma
to look at the deepest layers. An incisional biopsy removes only part
have a higher risk of getting it again. Gender: Men have a higher risk than women. Xeroderma pigmentation: People with this rare, inherited condition are at a greater risk of developing melanoma.
1
FDA Consumer Health Information, US Food and Drug Administration, May, 2010
of the tumor, while an excisional biopsy removes the entire tumor. Shave biopsy in which the doctor “shaves” off the top layers of skin. Punch biopsy in which a round tool cuts through all the layers of the skin and brings up a sample of tissue.
www.MDOnc.com
SKIN Cancer FACTS Treatment options are different for different types and stages of
THE KNOWLEDGE TO HEAL. THE COMPASSION TO CARE.
skin cancer, but may include chemotherapy, radiation therapy,
For over 20 years, Maryland Oncology Hematology has provided
or surgery. Each treatment option may be used alone or
comprehensive, compassionate care to patients facing cancer and
in combination.
blood disorders in the Maryland area. Our team of experienced
Chemotherapy is the use of drugs to kill cancer cells.
physicians, oncology certified nurses, and staff guides patients
Treatment
Topical chemotherapy is a medicine that is placed directly onto the skin. Systemic chemotherapy uses drugs taken by mouth or injected. This treatment can be used when the cancer has spread to other organs.
and their families through the latest advancements in treatment options. Maryland Oncology Hematology offers a full range of personalized chemotherapy services, laboratory testing, clinical trials and support services all conveniently located in a familiar community setting.
Radiation therapy is the use of high-energy rays to kill cancer cells in the treated area. It is usually administered from
Cheryl Aylesworth, MD
a machine outside the body. It may also be used after surgery
Thomas Bensinger, MD, FACP
to kill cancer cells that may remain after surgery. Surgery treatment for melanoma can include removal of the melanoma, amputation of a finger or toe, or removal of lymph nodes. Non-melanoma is most commonly treated with surgery, ranging from simple excisions to laser surgery, to lymph node surgery.
Frederick Min, MD Linda Burrell, MD Roopa De Chowdhury, MD Alida Espinoza, MD Kashif Firozvi, MD Kashif Ali, MD Kristin Sorensen, FNP-C
PREVENTION Seek shade, especially during midday hours Wear clothing to protect exposed skin Wear a hat with a wide brim to shade the face, head, ears, and neck Wear sunglasses that wrap around and block as close to 100% of both UVA and UVB rays as possible Use sunscreen with sun protective factor (SPF) 15 or higher, and both UVA and UVB protection Avoid indoor tanning
Greenbelt • Laurel • Silver Spring • Wheaton To learn more or to refer a patient, visit www.MDOnc.com
The Knowledge to Heal. The Compassion to Care Jon K. Minford, M.D.
Tejaswi R. Sastry, M.D.
Medical Oncology & Hematology
Medical Oncology & Hematology
Medical School: University of Pittsburgh School of Medicine Residency: New York University Medical Center Fellowship: National Cancer Institute Board Certifications: Internal Medicine and Medical Oncology Location: Columbia
Medical School: Kempegowda Institute of Medical Services Residency: University of North Carolina at Chapel Hill, Moses Cone Health Systems Fellowship: Eastern Carolina University Brody School of Medicine Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia
Nicholas W. Koutrelakos, M.D.
Mohit Narang, M.D.
Medical Oncology & Hematology
Medical School: Dayanand Medical College Residency: Christ Hospital Fellowship: Michigan State University Board Certifications: Internal Medicine and Medical Oncology Locations: Columbia and Gettysburg
Medical School: University of Maryland Residency: University of Massachusetts, Berkshire Medical School Fellowship: Brown University Board Certification: Medical Oncology Location: Columbia
Medical Oncology & Hematology
Robert L. Rice, M.D. Edward J. Lee, M.D. Medical Oncology & Hematology Medical School: State University of New York Downstate Medical College Residency: Baltimore City Hospital Fellowship: University of Maryland Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia
Medical Oncology & Hematology Medical School: University of Pittsburgh School of Medicine Residency: University Hospitals Case Medical Center Fellowship: Vanderbilt University Board Certifications: Internal Medicine, Medical Oncology and Hematology Location: Columbia and Gettysburg
Adam Schmuckler, P.A.-C., MMSc College: Syracuse University Graduate School: Emory University Location: Columbia
COLUMBIA 10710 Charter Drive, Suite G020 â&#x20AC;˘ Columbia, MD 21044 Phone: (410) 964-2212 â&#x20AC;˘ Fax: (410) 964-0380
MDOnc.com
WE ARE PROUD TO ANNOUNCE OUR NEW
LOCATION
12210 Plum Orchard Dr., Suite 211 Silver Spring, MD 20904
MARYLAND ONCOLOGY HEMATOLOGY
W E H AV E A N E W
WHITE OAK ADDRESS
Burtonsville
Cloverly 200
Aspen Hill
95
Colesville 12210 Plum Orchard Dr #211
Bethesda
Wheaton
White Oak
Beltsville
495
Adelphi
BETHESDA
Silver Spring
College Park
Takoma Park
Maryland Oncology Hematology is pleased to announce we have opened a new office in White Oak. We remain committed to providing the best oncology and hematology services in a community setting close to home. Our new state of the art infusion center, offers todayâ&#x20AC;&#x2122;s most effective therapies, expertly and compassionately delivered.
Our New Location
12210 Plum Orchard Dr., Suite 211 Silver Spring, MD 20904 To refer a patient, please call (301) 933-3216.
MDONC.COM
Maryland Oncology Hematology UPDATE Spring 2013
Our Physicians Kashif Ali, M.D. Manoj Agarwal, M.D., M.B.A. Cheryl Aylesworth, M.D. Thomas A. Bensinger M.D., F.A.C.P. Linda Burrell, M.D. Roopa De Chowdhury, M.D. Nicholas A. DeMonaco M.D., F.A.C.P. Alida Espinoza, M.D. Kashif Firozvi, M.D. Rita Gupta, M.D., F.A.C.P. David J. Haidak, M.D., F.A.C.P. Harvey I. Katzen, M.D., F.A.C.P. Nicholas W. Koutrelakos, M.D. Edward J. Lee, M.D. Jose Mendoza, M.D., F.A.C.P. Frederick Min, M.D. Jon K. Minford, M.D. Mohit Narang, M.D. Robert L. Rice, M.D., Ph.D. Tejaswi R. Sastry M.D. Jun Sun, M.D. Deepnarayan Tiwarri, M.D. Kai-Yiu Yeung, M.D., F.A.C.P. Ayana Elliott DNP, MS, APRN, F.N.P.-C. Adam Schmuckler P.A.-C., MMSc Kristin Sorensen N.P.-C., MS, R.N.
Oncology-Hematology Associates Joins Maryland Oncology Hematology Maryland Oncology Hematology is pleased to announce that Oncology-Hematology Associates, P.A. will join its practice, expanding and enhancing patient services as well as adding additional treatment locations in Clinton and Lanham, MD. Eight board-certified physicians will join Maryland Oncology Hematology’s group of 15 oncologists to offer state-of-the-art, comprehensive cancer care to oncology and hematology patients in the comfort and convenience of a patient-centered community setting. “We are pleased to welcome the physicians of Oncology-Hematology Associates to our practice,” said Jon Minford, M.D., medical oncologist and founder of Maryland Oncology Hematology. “Our collaboration with this team of like-minded, highly trained cancer specialists will allow us to expand and enhance our treatment model of providing high quality integrated, evidence-based cancer care and clinical research. Additionally, our patients will now have access to care in two more convenient locations in Maryland.” This merger with Oncology-Hematology Associates expands service offerings to Clinton and Lanham, MD with the addition of Drs. David J. Haidak, KaiYiu Yeung, Harvey I. Katzen, Rita Gupta, Deepnarayan Tiwarri, Nicholas A. DeMonaco, Jose L. Mendoza and Jun F. Sun. Featured physicians left to right: Top Row Dr. DeMonaco, Dr. Sun, Dr. Katzen, Dr. Tiwarri Bottom Row Dr. Mendoza, Dr. Haidak, Dr. Yeung, Dr. Gupta
mdonc.com
Meet Our New Physician Team Members Nicholas A. DeMonaco M.D., F.A.C.P. Medical School: Temple University School of Medicine
OUR LOCATIONS
Residency: University of Pittsburgh
Clinton 8926 Woodyard Road, Suite 101 Clinton, MD 20735 301-868-7911
Board Certifications: Internal Medicine, Medical Oncology, and Hematology
Fellowship: University of Pittsburgh
Locations: Clinton and Lanham
Rita Gupta, M.D., F.A.C.P. Medical School: Gandhi Medical College of Bhopal University Residency: Prince George Hospital Center Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Columbia 10710 Charter Drive, Suite G020 Columbia, Maryland 21044 410-964-2212
David J. Haidak, M.D., F.A.C.P.
Harvey I. Katzen, M.D., F.A.C.P.
Medical School: Albany Medical College
Medical School: George Washington Medical Center
Gettysburg 40 V Twin Drive, Suite 104 Gettysburg, PA 17325 717-338-9009
Residency: Georgetown University Hospital and D.C. General Hospital
Residency: George Washington University Hospital
Fellowship: Georgetown University Hospital and George Washington University Medical Center
Fellowship: George Washington University
Greenbelt 7525 Greenway Center Drive, Suite 205 Greenbelt, MD 20770 301-982-9800
Board Certifications: Internal Medicine, Medical Oncology, Hematology
Board Certifications: Internal Medicine and Medical Oncology
Locations: Clinton and Lanham
Locations: Clinton and Lanham
Lanham 8116 Good Luck Road, Suite100 Lanham, MD 20706 301-474-0427 Laurel 7350 Van Dusen Road, Suite 370 Laurel, MD 20707 301-982-9800 Pikesville 1838 Greene Tree Road, Suite 260 Pikesvlle, MD 21208 410-581-2100
Jose Mendoza, M.D F.A.C.P. Medical School: San Marcos National Major University Medical School Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Silver Spring 2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902 301-933-3216 Westminster 680 Poole Road, Suites A & B Westminster, MD 21157 410-581-2100 Wheaton 2730 University W Blvd., Suite 400 Wheaton, MD 20902 301-924-9220
Hospital
Jun Sun, M.D. Medical School: State University of New York at Buffalo School of Medicine Residency: Georgetown University Medical Center Fellowship: Georgetown Universityâ&#x20AC;&#x2122;s Lombardi Cancer Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Deepnarayan Tiwarri, M.D.
Kai-Yiu Yeung, M.D., F.A.C.P.
Medical School: Howard University College of Medicine
Medical School: National Taiwan University College of Medicine
Residency: Washington Hospital Center Fellowship: Georgetown University Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Residency: Veterans Administration Hospital Fellowship: George Washington University Medical Center Board Certifications: Internal Medicine, Medical Oncology and Hematology Locations: Clinton and Lanham
Maryland Oncology Hematology UPDATE Spring 2013
Kashif Ali, M.D.
Linda M. Burrell M.D.
Kashif Firozvi M.D.
Nicholas W. Koutrelakos, M.D.
Jon K. Minford M.D.
Jun Sun, M.D.
Manoj Agarwal M.D., M.B.A.
Roopa De Chowdhury, M.D.
Rita Gupta M.D., F.A.C.P.
Edward J. Lee M.D.
Mohit Narang M.D.
Deepnarayan Tiwarri, M.D.
Cheryl A. Aylesworth, M.D.
Nicholas A. DeMonaco M.D., F.A.C.P.
David J. Haidak M.D., F.A.C.P.
Jose Mendoza M.D., F.A.C.P.
Robert L. Rice M.D., Ph.D
Kai-Yiu Yeung M.D., F.A.C.P.
Thomas A. Bensinger M.D., F.A.C.P.
Alida Espinoza M.D.
Harvey I. Katzen M.D., F.A.C.P.
Frederick Min M.D.
Tejaswi R. Sastry M.D.
mdonc.com
2101 Medical Park Drive, Suite 200 Silver Spring, MD 20902
UNITED Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nationâ&#x20AC;&#x2122;s largest community-based cancer treatment and research networks dedicated to advancing cancer care and expanding patient access to high-quality care.
WE HEAL mdonc.com